NCT06228339View on ClinicalTrials.gov

The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 9, 2024

Primary Completion Date

March 14, 2024

Study Completion Date

March 21, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets

Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets (Test Drug)

DRUG

Xatral® XL 10 mg

Xatral® XL 10 mg (Reference Drug)

Sponsors
All Listed Sponsors
lead

International Bio service

NETWORK